Contact Us
Drug Search Results
More Filters [+]

Trelagliptin

Alternative Names: trelagliptin, syr-472
Latest Update: 2024-08-23
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: DPP4 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bangladesh | Japan

Approved Indications: None

Known Adverse Events: None

Company: Takeda
Company Location: TOKYO M0 103-8668
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Trelagliptin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Type 2 Diabetes|Tobacco Use Disorder

Phase 3: Type 2 Diabetes|General Diabetes|Kidney Failure, Chronic

Phase 2: General Diabetes|Weight Gain|Dyslipidemia|Insulin Resistance|Diabetes Mellitus, Lipoatrophic|Hypoglycemia|Diabetes Complications|Type 2 Diabetes|Hyperglycemia|Obesity, Morbid

Phase 1: Healthy Volunteers|Tachycardia, Ventricular|Obesity|Insulin Resistance|Conduct Disorder|Type 2 Diabetes

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
Trelagliptin-4004

N/A

Completed

Type 2 Diabetes

2023-01-31

JapicCTI-205186

N/A

Active

Type 2 Diabetes

2022-10-31

Trelagliptin-5001

N/A

Completed

Type 2 Diabetes

2021-10-31

JapicCTI-183980

N/A

Active

Type 2 Diabetes

2021-10-31

Recent News Events

Date

Type

Title

10/15/2023

PubMed

 Trelagliptin relieved cognitive impairment of diabetes mellitus rats: Involvement of PI3K/Akt/GSK-3beta and inflammation pathway.

09/30/2023

PubMed

 Impacts of trelagliptin and remogliflozin alone and in combination with Alpha Lipoic Acid on cardiac function in streptozotocin-induced diabetes mellitus in rats.

03/02/2023

PubMed

 Computational tools for exploring peptide-membrane interactions in gram-positive bacteria.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions